Functional abdominal pain

被引：28

作者：

Grover M. ^{[1
]}

Drossman D.A. ^{[2
]}

机构：

[1] Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905

[2] UNC Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC 27599-7080, 4150 Bioinformatics

来源：

Current Gastroenterology Reports | 2010年 / 12卷 / 5期

关键词：

Biopsychosocial; Chronic abdominal pain; Complementary therapy; Functional abdominal pain syndrome; Functional gastrointestinal disorders; Irritable bowel syndrome; Psychological treatments; Psychotropic agents;

D O I：

10.1007/s11894-010-0125-0

中图分类号：

学科分类号：

摘要：

Functional abdominal pain syndrome (FAPS) is a relatively less common functional gastrointestinal (GI) disorder defined by the presence of constant or frequently recurring abdominal pain that is not associated with eating, change in bowel habits, or menstrual periods (Drossman Gastroenterology 130:1377-1390, 2006), which points to a more centrally targeted (spinal and supraspinal) basis for the symptoms. However, FAPS is frequently confused with irritable bowel syndrome and other functional GI disorders in which abdominal pain is associated with eating and bowel movements. FAPS also differs from chronic abdominal pain associated with entities such as chronic pancreatitis or chronic inflammatory bowel disease, in which the pain is associated with peripherally acting factors (eg, gut inflammation or injury). Given the central contribution to the pain experience, concomitant psychosocial disturbances are common and strongly influence the clinical expression of FAPS, which also by definition is associated with loss of daily functioning. These factors make it critical to use a biopsychosocial construct to understand and manage FAPS, because gut-directed treatments are usually not successful in managing this condition. © 2010 Springer Science+Business Media, LLC.

引用

页码：391 / 398

页数：7

共 42 条

[21]

Jess P., Jess T., Beck H., Bech P., Neuroticism in relation to recovery and persisting pain after laparoscopic cholecystectomy, Scandinavian Journal of Gastroenterology, 33, 5, pp. 550-553, (1998)

[22]

Melzack R., Wall P., Gate-control and other mechanisms, The Challenge of Pain, pp. 165-193, (1988)

[23]

Drossman D.A., Whitehead W.E., Toner B.B., Et al., What determines severity among patients with painful functional bowel disorders?, Am J Gastroenterol, 95, pp. 974-980, (2000)

[24]

Mertz H.R., Altered CNS processing of visceral pain in IBS, Irritable Bowel Syndrome: Diagnosis and Treatment, pp. 55-68, (2002)

[25]

Mertz H., Morgan V., Tanner G., Et al., Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention, Gastroenterology, 118, pp. 842-848, (2000)

[26]

Naliboff B.D., Derbyshire S.W., Munakata J., Et al., Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation, Psychosom Med, 63, pp. 365-375, (2001)

[27]

Drossman D.A., Ringel Y., Vogt B.A., Leserman J., Lin W., Smith J.K., Whitehead W., Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome, Gastroenterology, 124, 3, pp. 754-761, (2003)

[28]

Morgan V., Pickens D., Gautam S., Kessler R., Mertz H., Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome, Gut, 54, 5, pp. 601-607, (2005)

[29]

Mayberg H.S., Brannan S.K., Mahurin R.K., Et al., Cingulate function in depression: A potential predictor of treatment response, Neuroreport, 8, pp. 1057-1061, (1997)

[30]

Grover M., Drossman D.A., Psychopharmacologic and behavioral treatments for functional gastrointestinal disorders, Gastrointest Endosc Clin N Am, 19, pp. 151-170, (2009)

← 1 2 3 4 5 →